Literature DB >> 6152401

The risk-benefit equation: when to initiate treatment.

J I Robertson.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6152401      PMCID： PMC1463466          DOI： 10.1111/j.1365-2125.1984.tb02596.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION.

Authors:  M HAMILTON; E M THOMPSON; T K WISNIEWSKI
Journal:  Lancet       Date:  1964-02-01       Impact factor: 79.321

2.  Combined treatment of severe intractable hypertension with captopril and diuretic.

Authors:  A B Atkinson; J J Brown; A F Lever; J I Robertson
Journal:  Lancet       Date:  1980-07-19       Impact factor: 79.321

3.  Captopril: five years on.

Authors:  G P Hodsman; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

4.  "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.

Authors:  D McAreavey; L E Ramsey; L Latham; A D McLaren; A R Lorimer; J L Reid; J I Robertson; M P Robertson; R J Weir
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-14

5.  Angiotensin converting enzyme inhibition in heart failure.

Authors:  J G Cleland; H J Dargie; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335
  5 in total
  1 in total

Review 1.  The large studies in hypertension: what have they shown?

Authors:  J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1987       Impact factor: 4.335
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.